Literature DB >> 25640033

Structural and functional characterization of the acidic region from the RIZ tumor suppressor.

Yizhi Sun1, Jessica M Stine, Daniel Z Atwater, Ayesha Sharmin, J B Alexander Ross, Klára Briknarová.   

Abstract

RIZ (retinoblastoma protein-interacting zinc finger protein), also denoted PRDM2, is a transcriptional regulator and tumor suppressor. It was initially identified because of its ability to interact with another well-established tumor suppressor, the retinoblastoma protein (Rb). A short motif, IRCDE, in the acidic region (AR) of RIZ was reported to play an important role in the interaction with the pocket domain of Rb. The IRCDE motif is similar to a consensus Rb-binding sequence LXCXE (where X denotes any amino acid) that is found in several viral Rb-inactivating oncoproteins. To improve our understanding of the molecular basis of binding of Rb to RIZ, we investigated the interaction between purified recombinant AR and the pocket domain of Rb using nuclear magnetic resonance spectroscopy, isothermal titration calorimetry, and fluorescence anisotropy experiments. We show that AR is intrinsically disordered and that it binds the pocket domain with submicromolar affinity. We also demonstrate that the interaction between AR and the pocket domain is mediated primarily by the short stretch of residues containing the IRCDE motif and that the contribution of other parts of AR to the interaction with the pocket domain is minimal. Overall, our data provide clear evidence that RIZ is one of the few cellular proteins that can interact directly with the LXCXE-binding cleft on Rb.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640033      PMCID: PMC4371781          DOI: 10.1021/bi501398w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  56 in total

1.  cDNA cloning of a novel protein containing two zinc-finger domains that may function as a transcription factor for the human heme-oxygenase-1 gene.

Authors:  Y Muraosa; K Takahashi; M Yoshizawa; S Shibahara
Journal:  Eur J Biochem       Date:  1996-02-01

2.  Structural studies of the SET domain from RIZ1 tumor suppressor.

Authors:  Klára Briknarová; Xin Zhou; Arnold Satterthwait; David W Hoyt; Kathryn R Ely; Shi Huang
Journal:  Biochem Biophys Res Commun       Date:  2007-12-17       Impact factor: 3.575

3.  Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor.

Authors:  Xin Liu; Ronen Marmorstein
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

4.  A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence.

Authors:  Srikanth Talluri; Christian E Isaac; Mohammad Ahmad; Shauna A Henley; Sarah M Francis; Alison L Martens; Rod Bremner; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

5.  In vitro analysis of the E1A-homologous sequences of RIZ.

Authors:  I M Buyse; S Huang
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Retinoblastoma protein recruits histone deacetylase to repress transcription.

Authors:  A Brehm; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

7.  The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter.

Authors:  L Liu; G Shao; G Steele-Perkins; S Huang
Journal:  J Biol Chem       Date:  1997-01-31       Impact factor: 5.157

8.  Transcriptional repression mediated by the PR domain zinc finger gene RIZ.

Authors:  M Xie; G Shao; I M Buyse; S Huang
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

9.  Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.

Authors:  Josephine C Ferreon; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

10.  RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.

Authors:  Ashakumary Lakshmikuttyamma; Naoto Takahashi; Elodie Pastural; Emina Torlakovic; Hesham M Amin; Guillermo Garcia-Manero; Michael Voralia; Magdalena Czader; John F DeCoteau; C Ronald Geyer
Journal:  J Hematol Oncol       Date:  2009-07-14       Impact factor: 17.388

View more
  3 in total

1.  The Interaction between the Third Type III Domain from Fibronectin and Anastellin Involves β-Strand Exchange.

Authors:  Jessica M Stine; Gabriel J H Ahl; Casey Schlenker; Domnita-Valeria Rusnac; Klára Briknarová
Journal:  Biochemistry       Date:  2017-08-18       Impact factor: 3.162

2.  Structural basis for tunable affinity and specificity of LxCxE-dependent protein interactions with the retinoblastoma protein family.

Authors:  Sivasankar Putta; Lucia Alvarez; Stephan Lüdtke; Peter Sehr; Gerd A Müller; Samantha M Fernandez; Sarvind Tripathi; Joe Lewis; Toby J Gibson; Lucia B Chemes; Seth M Rubin
Journal:  Structure       Date:  2022-06-17       Impact factor: 5.871

3.  Repression of Akt3 gene transcription by the tumor suppressor RIZ1.

Authors:  Qingnan Liu; Xiaotian Qu; Xiaolei Xie; Pei He; Shi Huang
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.